BBK Worldwide Blog

Facilitating the Journey from Patient to Study Participant

Posted by Elizabeth Gargill on Wed, Apr 27, 2022

Pharma15 Live!

Facilitating the Journey from Patient to Study Participant

The Impact of Dynamic Referral Processing

Matt Kibby and Aaron Fleishman return to the Pharma15 Live! stage to discuss BBK's dynamic referral processing service and how it improves and accelerates the patient enrollment process. 

"Our process benefits both patients and sites alike. It unburdens the study staff, creating a better experience for them, while also ensuring patients are responded to more quickly and with better care so their journey is a positive one."

-Matt Kibby, President, Chief Strategy Officer, BBK Worldwide

Watch Now

Read More

Topics: Pharma15 Live!, Call Centers, Matt Kibby, Aaron Fleishman, Hybrid Clinical Trials, Dynamic Referral Processing, Secondary Prescreening

Blueprint for Success: Proven Strategies for Patient Engagement

Posted by Aaron Fleishman on Tue, Apr 19, 2022

 

 

Blueprint for Success: Proven Strategies for Patient Engagement

Download our blueprint for patient engagement and get a compilation of ideas and proven strategies to help you and your clinical trial team create a successful patient engagement program.

Download Now

Read More

Topics: Patient Engagement, Aaron Fleishman, Free Download, Hybrid

Prioritizing the Patient Voice with Hybrid Clinical Trials

Posted by Elizabeth Gargill on Tue, Mar 8, 2022

 

New survey findings reveal the importance of offering patients choice when it comes to improving clinical trial diversity, access, and engagement.

Patients want options, or choice, when it comes to clinical trial participation. New data from a recent Study Voices survey reveals the impact choice can have on participation. The findings empower clinical trial sponsors to shift from traditional clinical trial models to hybrid models with confidence.

 

DOWNLOAD NOW

Read More

Topics: Most Viewed, Study Voices, Aaron Fleishman, International Clinical Trials, Surveys, Hybrid Clinical Trials

2022: A Look into Our Crystal Ball

Posted by Elizabeth Gargill on Wed, Jan 5, 2022

 

The clinical trial landscape saw a lot of changes in 2021, from decentralized clinical trial adoption to a greater emphasis on diversity and inclusion. But what’s in store for 2022? We asked our industry experts to weigh in with their predictions.

Read More

Topics: Most Viewed, Aaron Fleishman, Mike Johnson, Danielle Frate, Dena Raffa, 2022 Predictions, Justin Jones, Crystal Ball

2021: A Look Inside Our Crystal Ball (part two)

Posted by Elizabeth Gargill on Tue, Dec 22, 2020

 

For part two of our Crystal Ball series, we asked a few more of our industry experts to comment on the clinical research landscape and to share their predictions for 2021.

Rob Laurens, Principal, RSG Services

 

Do you think a lot of the travel services rapidly deployed in response to COVID-19 will remain in effect? Will they become part of the standard offering?

Undoubtedly, many of the extraordinary support services deployed as a means to directly respond to the impact of the COVID-19 pandemic on clinical trial participant travel not only will remain available after the distribution and anticipated positive impact of vaccines, but also will be enhanced to serve the needs of a redefined approach and capabilities for clinical trial conduct by sponsors and CROs. 

Read More

Topics: BBK Worldwide, Patient Engagement, Patient Travel, Patient Experience, Patient Enrollment, Rob Laurens, Aaron Fleishman, Clinical Trial Patient Travel, Decentralized Trials, Virtual, Hybrid Trials, 2021 Predictions, 2021

Survey Reveals Site Perspectives on Clinical Trial Services

Posted by Elizabeth Gargill on Tue, Dec 1, 2020

What do doctors and nurses think about solutions designed to make clinical trials easier to conduct? Are they helpful? Do they alleviate burdens? And which ones do they prefer?

In this special Pharma15 Live! segment, BBK Worldwide® industry experts Matt Kibby and Aaron Fleishman discuss recent Study Voices survey results that shed light on this topic. They examine doctor and nurse perspectives on services designed to provide support in conducting clinical trials — including services for virtual, hybrid, and decentralized clinical trials.

“We were looking at whether or not doctors and nurses at sites that were conducting clinical trials would appreciate different types of services that assist with their ability to conduct them."

-Matt Kibby, Principal, President, BBK Worldwide

Read More

Topics: Clinical Trials, Pharma15 Live!, Most Viewed, Study Voices, COVID-19, Matt Kibby, Aaron Fleishman, Decentralized Trials, Study Voices 2020, Hybrid Trials

Pharma15 Live! Director’s Chair

Posted by Aaron Fleishman on Fri, Jul 17, 2020

 

As the director and one of the producers of Pharma15 Live! I wanted to share with you some insights into what we’ve learned through an amazing three seasons! First of all, if you were to tell me at the beginning of our series that it would even last three seasons, I’d tell you I’d be shocked – but nonetheless here we are and it’s been great!

Read More

Topics: Pharma15 Live!, COVID-19, Matt Kibby, Aaron Fleishman, Craig Lipset, Advarra, Season Three, Michele Russell-Einhorn, Dan Sfera, Ray Dorsey, MD

Bonus Content: COVID-19 and Beyond Virtual Town Hall

Posted by Elizabeth Gargill on Tue, May 26, 2020

More of Your Questions Answered

In this special video clip, industry innovators Aaron Fleishman and Craig Lipset answer some of the overflow questions from our Virtual Town Hall on maintaining clinical trial momentum during COVID-19 and beyond.

This 20-minute segment features answers to your questions relating to:

  • Implementation of decentralized trials
  • Impact of COVID-19 on enrollment of healthy volunteers
  • Biggest concerns for clinicians around remote contact with patients
  • Advancing decentralized trials while not leaving behind people without access to reliable internet, electronic devices, or digital savvy
  • Validating new digital endpoints for decentralized trials
  • Impact of telemedicine and other decentralized trial approaches on  monitoring and source data verification (SDV)

 

Read More

Topics: Webinars, Clinical Trials, Pharma15 Live!, COVID-19, Aaron Fleishman, Craig Lipset

Watch Now: COVID-19 and Beyond Virtual Town Hall

Posted by Elizabeth Gargill on Tue, May 19, 2020

Driven by audience questions, industry innovators Aaron Fleishman and Craig Lipset discuss maintaining clinical trial momentum during COVID-19 and beyond during our recent virtual town hall.

Watch now to gain insight into overcoming patient enrollment and engagement challenges while supporting study continuity. Learn how to minimize clinical trial disruption with solutions for all stages of study activity – planning, enrolling, and even restarting.

Read More

Topics: Webinars, Clinical Trials, Pharma15 Live!, COVID-19, Aaron Fleishman, Craig Lipset

"COVID-19 and Beyond" Virtual Town Hall

Posted by Elizabeth Gargill on Wed, May 6, 2020

"COVID-19 and Beyond" Virtual Town Hall - May 14, 2020 @ 12:00 p.m. ET

Join industry innovators Craig Lipset and Aaron Fleishman for a virtual town hall to discuss maintaining clinical trial momentum during COVID-19 and beyond. Register now.

Read More

Topics: Webinars, Clinical Trials, Pharma15 Live!, COVID-19, Aaron Fleishman, Craig Lipset